ID   VIME_RAT                Reviewed;         466 AA.
AC   P31000;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 187.
DE   RecName: Full=Vimentin {ECO:0000312|RGD:621646};
GN   Name=Vim {ECO:0000312|RGD:621646};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Fischer;
RX   PubMed=1540169; DOI=10.1016/0006-291x(92)91866-o;
RA   Bussemakers M.J.G., Verhaegh G.W.C.T., van Bokhoven A., Debruyne F.M.J.,
RA   Schalken J.A.;
RT   "Differential expression of vimentin in rat prostatic tumors.";
RL   Biochem. Biophys. Res. Commun. 182:1254-1259(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 37-50, AND SUBCELLULAR LOCATION.
RC   TISSUE=Liver;
RX   PubMed=16128803; DOI=10.1111/j.1742-4658.2005.04847.x;
RA   Segawa M., Niino K., Mineki R., Kaga N., Murayama K., Sugimoto K.,
RA   Watanabe Y., Furukawa K., Horigome T.;
RT   "Proteome analysis of a rat liver nuclear insoluble protein fraction and
RT   localization of a novel protein, ISP36, to compartments in the
RT   interchromatin space.";
RL   FEBS J. 272:4327-4338(2005).
RN   [4]
RP   PROTEIN SEQUENCE OF 51-64; 123-129; 223-235; 295-304; 321-341; 346-364;
RP   391-401 AND 411-424, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 86-160.
RC   TISSUE=Mammary gland;
RA   Paine M.L.;
RL   Submitted (FEB-1992) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION.
RX   PubMed=2192768; DOI=10.1016/0248-4900(90)90299-i;
RA   Katsumoto T., Mitsushima A., Kurimura T.;
RT   "The role of the vimentin intermediate filaments in rat 3Y1 cells
RT   elucidated by immunoelectron microscopy and computer-graphic
RT   reconstruction.";
RL   Biol. Cell 68:139-146(1990).
RN   [7]
RP   INTERACTION WITH RAB8B.
RX   PubMed=12639940; DOI=10.1210/en.2002-220893;
RA   Lau A.S., Mruk D.D.;
RT   "Rab8B GTPase and junction dynamics in the testis.";
RL   Endocrinology 144:1549-1563(2003).
RN   [8]
RP   PHOSPHORYLATION AT SER-55, AND MUTAGENESIS OF SER-55 AND 458-THR-SER-459.
RX   PubMed=12686602; DOI=10.1091/mbc.e02-08-0545;
RA   Chou Y.-H., Khuon S., Herrmann H., Goldman R.D.;
RT   "Nestin promotes the phosphorylation-dependent disassembly of vimentin
RT   intermediate filaments during mitosis.";
RL   Mol. Biol. Cell 14:1468-1478(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51; SER-56; SER-83; SER-144;
RP   SER-214; SER-412; SER-419; SER-420; SER-430 AND SER-459, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Vimentins are class-III intermediate filaments found in
CC       various non-epithelial cells, especially mesenchymal cells. Vimentin is
CC       attached to the nucleus, endoplasmic reticulum, and mitochondria,
CC       either laterally or terminally. Plays a role in cell directional
CC       movement, orientation, cell sheet organization and Golgi complex
CC       polarization at the cell migration front (By similarity). Protects
CC       SCRIB from proteasomal degradation and facilitates its localization to
CC       intermediate filaments in a cell contact-mediated manner (By
CC       similarity). {ECO:0000250|UniProtKB:A0A8C0N8E3,
CC       ECO:0000269|PubMed:2192768}.
CC   -!- FUNCTION: Involved with LARP6 in the stabilization of type I collagen
CC       mRNAs for CO1A1 and CO1A2. {ECO:0000250|UniProtKB:P08670}.
CC   -!- SUBUNIT: Homomer assembled from elementary dimers (By similarity).
CC       Identified in complexes that contain VIM, EZR, AHNAK, BFSP1, BFSP2,
CC       ANK2, PLEC, PRX and spectrin (By similarity). Interacts with BCAS3 (By
CC       similarity). Interacts with LGSN (By similarity). Interacts with SYNM
CC       (By similarity). Interacts (via rod region) with PLEC (via CH 1 domain)
CC       (By similarity). Interacts with STK33 (By similarity). Interacts with
CC       LARP6 (By similarity). Interacts with RAB8B (PubMed:12639940).
CC       Interacts with TOR1A; the interaction associates TOR1A with the
CC       cytoskeleton. Interacts with TOR1AIP1 (By similarity). Interacts with
CC       TOR1AIP1 (By similarity). Interacts with DIAPH1 (By similarity).
CC       Interacts with EPPK1; interaction is dependent of higher-order
CC       structure of intermediate filament (By similarity). Interacts with the
CC       non-receptor tyrosine kinase SRMS; the interaction leads to
CC       phosphorylation of VIM (By similarity). Interacts with NOD2 (By
CC       similarity). Interacts (via head region) with CORO1C (By similarity).
CC       Interacts with HDGF (By similarity). Interacts with PRKCE (via phorbol-
CC       ester/DAG-type 2 domain) (By similarity). Interacts with BFSP2 (By
CC       similarity). Interacts with PPL (By similarity). Interacts with PKP1
CC       and PKP2 (By similarity). Interacts with SCRIB (via PDZ domains); the
CC       interaction protects SCRIB from proteasomal degradation and facilitates
CC       SCRIB localization to intermediate filaments, the interaction is
CC       reduced by cell contact inhibition (By similarity).
CC       {ECO:0000250|UniProtKB:P08670, ECO:0000250|UniProtKB:P20152,
CC       ECO:0000269|PubMed:12639940}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P08670}.
CC       Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:P08670}. Nucleus matrix
CC       {ECO:0000269|PubMed:16128803}. Cell membrane
CC       {ECO:0000250|UniProtKB:P20152}.
CC   -!- DOMAIN: The central alpha-helical coiled-coil IF rod domain mediates
CC       elementary homodimerization. {ECO:0000250|UniProtKB:P08670}.
CC   -!- DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for
CC       cysteine S-nitrosylation mediated by the iNOS-S100A8/A9
CC       transnitrosylase complex. {ECO:0000250|UniProtKB:P08670}.
CC   -!- PTM: One of the most prominent phosphoproteins in various cells of
CC       mesenchymal origin (By similarity). Phosphorylation is enhanced during
CC       cell division, at which time vimentin filaments are significantly
CC       reorganized (By similarity). Phosphorylation by PKN1 inhibits the
CC       formation of filaments (By similarity). Filament disassembly during
CC       mitosis is promoted by phosphorylation at Ser-55 as well as by nestin
CC       (PubMed:12686602). Phosphorylated at Ser-56 by CDK5 during neutrophil
CC       secretion in the cytoplasm (By similarity). Phosphorylated by STK33 (By
CC       similarity). Phosphorylated on tyrosine residues by SRMS (By
CC       similarity). {ECO:0000250|UniProtKB:P08670,
CC       ECO:0000269|PubMed:12686602}.
CC   -!- PTM: S-nitrosylation is induced by interferon-gamma and oxidatively-
CC       modified low-densitity lipoprotein (LDL(ox)) possibly implicating the
CC       iNOS-S100A8/9 transnitrosylase complex. {ECO:0000250|UniProtKB:P08670}.
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X62952; CAA44722.1; -; mRNA.
DR   EMBL; BC061847; AAH61847.1; -; mRNA.
DR   EMBL; M84481; AAA42339.1; -; mRNA.
DR   PIR; S22119; S22119.
DR   RefSeq; NP_112402.1; NM_031140.1.
DR   AlphaFoldDB; P31000; -.
DR   SMR; P31000; -.
DR   BioGRID; 249676; 12.
DR   CORUM; P31000; -.
DR   DIP; DIP-31882N; -.
DR   IntAct; P31000; 15.
DR   MINT; P31000; -.
DR   STRING; 10116.ENSRNOP00000024430; -.
DR   CarbonylDB; P31000; -.
DR   GlyCosmos; P31000; 3 sites, No reported glycans.
DR   GlyGen; P31000; 4 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P31000; -.
DR   PhosphoSitePlus; P31000; -.
DR   SwissPalm; P31000; -.
DR   jPOST; P31000; -.
DR   PaxDb; 10116-ENSRNOP00000024430; -.
DR   Ensembl; ENSRNOT00055018151; ENSRNOP00055014587; ENSRNOG00055010730.
DR   Ensembl; ENSRNOT00060014653; ENSRNOP00060011307; ENSRNOG00060008754.
DR   Ensembl; ENSRNOT00065010581; ENSRNOP00065007801; ENSRNOG00065006791.
DR   GeneID; 81818; -.
DR   KEGG; rno:81818; -.
DR   UCSC; RGD:621646; rat.
DR   AGR; RGD:621646; -.
DR   CTD; 7431; -.
DR   RGD; 621646; Vim.
DR   eggNOG; KOG0977; Eukaryota.
DR   InParanoid; P31000; -.
DR   OrthoDB; 4640531at2759; -.
DR   PhylomeDB; P31000; -.
DR   Reactome; R-RNO-264870; Caspase-mediated cleavage of cytoskeletal proteins.
DR   Reactome; R-RNO-390522; Striated Muscle Contraction.
DR   Reactome; R-RNO-9013422; RHOBTB1 GTPase cycle.
DR   Reactome; R-RNO-9646399; Aggrephagy.
DR   PRO; PR:P31000; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0044297; C:cell body; IDA:RGD.
DR   GO; GO:0031252; C:cell leading edge; ISO:RGD.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005882; C:intermediate filament; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005777; C:peroxisome; ISO:RGD.
DR   GO; GO:0045335; C:phagocytic vesicle; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045098; C:type III intermediate filament; TAS:RGD.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:1990254; F:keratin filament binding; ISO:RGD.
DR   GO; GO:0019900; F:kinase binding; IPI:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:RGD.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; IPI:RGD.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005212; F:structural constituent of eye lens; ISO:RGD.
DR   GO; GO:0005198; F:structural molecule activity; TAS:RGD.
DR   GO; GO:0014002; P:astrocyte development; ISO:RGD.
DR   GO; GO:0060020; P:Bergmann glial cell differentiation; ISO:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0071225; P:cellular response to muramyl dipeptide; ISS:UniProtKB.
DR   GO; GO:0071346; P:cellular response to type II interferon; ISO:RGD.
DR   GO; GO:0046697; P:decidualization; IEP:RGD.
DR   GO; GO:0045444; P:fat cell differentiation; IEP:RGD.
DR   GO; GO:0045109; P:intermediate filament organization; ISS:UniProtKB.
DR   GO; GO:0045103; P:intermediate filament-based process; ISO:RGD.
DR   GO; GO:0070307; P:lens fiber cell development; ISO:RGD.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; ISO:RGD.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; IMP:RGD.
DR   GO; GO:0050770; P:regulation of axonogenesis; IDA:RGD.
DR   GO; GO:0043488; P:regulation of mRNA stability; ISO:RGD.
DR   GO; GO:1900147; P:regulation of Schwann cell migration; IDA:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0010269; P:response to selenium ion; IEP:RGD.
DR   GO; GO:0033280; P:response to vitamin D; IEP:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IEP:RGD.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEP:RGD.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 1.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR006821; Intermed_filament_DNA-bd.
DR   InterPro; IPR050405; Intermediate_filament.
DR   PANTHER; PTHR45652; GLIAL FIBRILLARY ACIDIC PROTEIN; 1.
DR   PANTHER; PTHR45652:SF5; VIMENTIN; 1.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF04732; Filament_head; 1.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF64593; Intermediate filament protein, coiled coil region; 2.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Glycoprotein; Intermediate filament;
KW   Isopeptide bond; Membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   S-nitrosylation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CHAIN           2..466
FT                   /note="Vimentin"
FT                   /id="PRO_0000063759"
FT   DOMAIN          103..411
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2..95
FT                   /note="Head"
FT   REGION          96..131
FT                   /note="Coil 1A"
FT   REGION          132..153
FT                   /note="Linker 1"
FT   REGION          154..245
FT                   /note="Coil 1B"
FT   REGION          246..268
FT                   /note="Linker 12"
FT   REGION          269..407
FT                   /note="Coil 2"
FT   REGION          408..466
FT                   /note="Tail"
FT   COILED          96..131
FT   COILED          154..245
FT   COILED          303..407
FT   MOTIF           326..329
FT                   /note="[IL]-x-C-x-x-[DE] motif"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   SITE            351
FT                   /note="Stutter"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         5
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         7
FT                   /note="Phosphoserine; by PKA and PKC; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         9
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         10
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         20
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         34
FT                   /note="Phosphoserine; by PKC; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         39
FT                   /note="Phosphoserine; by CaMK2, PKA, PKC and ROCK2"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         42
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         47
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         49
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         53
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         55
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12686602"
FT   MOD_RES         56
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         61
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         66
FT                   /note="Phosphoserine; by PKA and PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         72
FT                   /note="Phosphoserine; by AURKB and ROCK2"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         73
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         83
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         117
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         120
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         120
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         129
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         129
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         139
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         144
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         168
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         188
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         188
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         223
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         226
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         235
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         294
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         294
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         373
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         409
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         412
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         419
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         420
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         426
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         430
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         436
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         445
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         445
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20152"
FT   MOD_RES         446
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         458
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MOD_RES         459
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        7
FT                   /note="O-linked (GlcNAc) serine; alternate"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        33
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        34
FT                   /note="O-linked (GlcNAc) serine; alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        104
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        129
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        139
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        223
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        262
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        294
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        313
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        373
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        439
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        445
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   CROSSLNK        445
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08670"
FT   MUTAGEN         55
FT                   /note="S->A: Retains filamentous network during mitosis
FT                   when transfected alone and when coexpressed with nestin."
FT                   /evidence="ECO:0000269|PubMed:12686602"
FT   MUTAGEN         458..459
FT                   /note="TS->AA: Induces loss of filamentous network when
FT                   coexpressed with nestin."
FT                   /evidence="ECO:0000269|PubMed:12686602"
SQ   SEQUENCE   466 AA;  53733 MW;  501CDCD706166829 CRC64;
     MSTRSVSSSS YRRMFGGSGT SSRPSSNRSY VTTSTRTYSL GSALRPSTSR SLYSSSPGGA
     YVTRSSAVRL RSSMPGVRLL QDSVDFSLAD AINTEFKNTR TNEKVELQEL NDRFANYIDK
     VRFLEQQNKI LLAELEQLKG QGKSRLGDLY EEEMRELRRQ VDQLTNDKAR VEVERDNLAE
     DIMRLREKLQ EEMLQREEAE STLQSFRQDV DNASLARLDL ERKVESLQEE IAFLKKLHDE
     EIQELQAQIQ EQHVQIDVDV SKPDLTAALR DVRQQYESVA AKNLQEAEEW YKSKFADLSE
     AANRNNDALR QAKQESNEYR RQVQSLTCEV DALKGTNESL ERQMREMEEN FALEAANYQD
     TIGRLQDEIQ NMKEEMARHL REYQDLLNVK MALDIEIATY RKLLEGEESR ISLPLPNFSS
     LNLRETNLES LPLVDTHSKR TLLIKTVETR DGQVINETSQ HHDDLE
//
